SCHEMBL15933725

SCHEMBL15933725

O=C(O)c1ccc(NC(=O)c2cc(CF)ccc2Oc2ccc(F)cc2Cl)cn1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15933729 0.91 — —
SCHEMBL15933730 0.89 — —
SCHEMBL15933510 0.88 — —
SCHEMBL15933700 0.87 — —
SCHEMBL15561766 0.87 — —
SCHEMBL15933728 0.86 — —
SCHEMBL15561883 0.85 — —
SCHEMBL21130229 0.84 — —
SCHEMBL15933723 0.84 P4HTM (0.57) —
SCHEMBL15933652 0.83 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9108903-B2 Amides as modulators of sodium channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2015-08-18 — — US disclosed
US-20140221435-A1 AMIDES AS MODULATORS OF SODIUM CHANNELS VERTEX PHARMACEUTICALS INCORPORATED (US) 2014-08-07 — — US disclosed
Send feedback